Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-02-20 @ 10:45 PM
Study NCT ID:
NCT02436759
Status:
COMPLETED
Last Update Posted:
2021-10-28
First Post:
2015-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Sponsor:
RVL Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-04
First Submit QC Date:
None
Study First Post Date:
2015-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-25
Results First Submit QC Date:
None
Results First Post Date:
2020-10-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-26
Last Update Post Date:
2021-10-28
Last Update Post Date Type:
ACTUAL